A new study has identified an enzyme that plays an important role in breaking down unneeded or damaged proteins in the heart – an important process for maintaining heart health.
This enzyme efficiently promotes a wide variety of S N Ar processes and can generate target products in a single mirror-image form, which is crucial for applications in the pharmaceutical sector.
Ecovyst Inc. (NYSE: ECVT), a leading integrated and innovative global provider of advanced materials, specialty catalysts, sulfuric acid and regeneration services ("Ecovyst"), and ChiralVision B.V., a ...
Catalysts companies Ecovyst Inc. (Malvern, Pa.) and ChiralVision B.V. (Den Hoorn, the Netherlands) signed a Memorandum of Understanding (MOU) to enhance ...